FORMULATION AND EVALUATION OF FAMOTIDINE MICRO BALLOONS WITH ENHANCED ANTI-ULCER ACTIVITY
Objective: The aim of the present study was to formulate and optimize famotidine loaded micro balloons for enhancing bioavailability, increasing gastric residence time of drug and to achieve sustained release in the stomach.
Methods: Microballoons were prepared using emulsion solvent diffusion method using HPMC K4M as the polymer. All the formulated microspheres were subjected to various evaluation parameters such as % drug entrapment, micromeritics properties, % buoyancy and in vitro drug release studies. The formulation was optimized using 32 full factorial design. Optimized formulation was subjective to in vivo floating (X-ray) and in vivo antiulcer studies.
Results: The microballoons were smooth and spherical in shape and were porous in nature due to hollow cavity. Sustained/controlled release of drug was observed for more than 12â€‰h. based on the results of % drug entrapment, in vitro drug release and % buoyancy studies, formulation F6 was selected as optimized formulation. The release kinetics of optimized formulation followed Higuchi model and mechanism of release was non-Fickian diffusion. Examination of the X-ray radiographic images taken during the study indicated that the optimized formulation remained buoyant and uniformly distributed in the gastric contents for a long period. In ethanol-induced ulcer model, drug-loaded microballoons treated group showed significant ulcer protection index of 83.26% as compared to the marketed brand of famotidine 76. 09% and untreated control group.
Conclusion: Famotidine-loaded floating micro balloons were successfully prepared and prove to be useful for the prolonged gastric residence of the drug, better bioavailability, patient compliance and anti-ulcer activity.
2. Kumar R, Chandra A, Gautam PK. Development and validation of UV spectrophotometric method for quantitative estimation of famotidine in bulk and tablet dosage form. Asian J Pharm Clin Res 2017;10:381-5.
3. United States Pharmacopoeia 32, National Formulary 27, Rockville MD: United States Pharma copoeial Convention 2009;2:2342-5.
4. Kumar R, Kamboj S, Chandra A, Gautam PK. Microballoons: an advance avenue for gastro-retentive drug delivery system-a review. UK J Pharm Biosci 2016;4:19-30.
5. Kumar R, Gupta S, Chandra A, Gautam PK. Floating tablets: a realistic approach in gastro-retentive drug delivery system. Int J Pharm Res Bio Sci 2016;5:1-20.
6. Kumar R, Philip A. Gastroretentive dosage forms for prolonging gastric residence time. Int J Pharm Med 2007;21:157-71.
7. Skoog DA, Holler FJ, Crouch SR. Instrumental analysis. 11th ed. Delhi: Cengage Learning India Pvt Ltd; 2012.
8. Kalsi PS. Spectroscopy of organic compounds. 6th ed. New Delhi: New age International Publishers; 2012.
9. Sharma YR. Introduction of organic spectroscopy. 4th ed. New Delhi: CBS Publishers and Distributors; 1991.
10. Joshi VK, Jaimini M. Microballons drug delivery system: a review. Asian J Pharm Res Dev 2013;1:7-17.
11. Aulton ME. Pharmaceutics: the science of dosage form design. 2nd ed. New York: Churchill Livingstone; 2002.
12. Martin A. Physical pharmacy. 4th ed. New Delhi: B I Waverly Pvt Ltd; 1996.
13. Kumar R, Chandra A, Saloni S, Gautam PK. Advanced multiple units controlled release floating beads: a review. World J Pharm Res 2017;6:238-59.
14. Mali AD, Bathe RS. An updated review on microballoons for a better approach in gastroretnton. AJP Sci 2015;5:188-92.
15. Huber L. Validation of analytical methods and processes. In: The Pharmaceutical codex, Principles and practice of pharmaceutics. 12th ed. London: The Pharmaceutical Press; 1994. p. 507-24.
16. Kumar R, Chandra A, Gupta S, Gautam PK. Development and validation of UV Method for quantitative estimation of lafutidine in bulk and tablet dosage form. Int J Appl Pharm 2017;9:75-9.
17. Kumar R. Development and in vitro evaluation of sustained release floating matrix tablets of metformin hydrochloride. Int J Pharm Sci Res 2010;1:96-101:13-7.
18. Bolton S. Pharmaceutical statistics practical and clinical applications. 4th ed. New York: Marcel Decker Inc; 2004.
19. Yang L, Fassihi R. Zero-order release kinetics from the self-correcting floatable configuration drug delivery system. J Pharm Sci 1996;85:170-3.
20. Mulye NV, Turco SJ. A simple model based on first-order kinetics to explain the release of highly water-soluble drugs from porous dicalcium phosphate dihydrate matrices. Drug Dev Ind Pharm 1995;21:943-53.
21. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of the rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
22. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
23. Kumar R, Chandra A, Garg S. Formulation and in vitro evaluation of sustained release gastro-retentive tablets of metformin hydrochloride. Int J Thera Appl 2012;7:13-7.
24. Gupta R, Prajapati SK, Pattnaik S, Bhardwaj P. Formulation and evaluation of novel stomach specific floating microspheres bearing famotidine for treatment of gastric ulcer and their radiographic study. Asian Pac J Trop Biomed 2014;4:729-35.
25. Sharma M, Kohli S, Dinda A. In vitro and in vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. Saudi Pharm J 2015;23:675-82.
26. Sawant K, Patel M, Patel J, Mundada P. Formulation, optimization, characterization and in vivo anti-ulcer activity of esomeprazole magnesium trihydrate gastroresistant microspheres. Int J Pharm Pharm Sci 2017;9:273-82.
27. Sabry SA, Hasan AA, Abdallah MH. Gastroretentive nizatidine loading microballoons for treatment of peptic ulcer. Int J Pharm Pharm Sci 2015;7:220-5.